Hepatitis C virus infection and extrahepatic malignancies

Area of Science:

• Hepatology
• Oncology
• Infectious Diseases

Background:

• Chronic hepatitis C (HCV) is a known risk factor for non-Hodgkin's lymphoma.
• The potential link between HCV and other extrahepatic malignancies requires further investigation.

Purpose of the Study:

• To evaluate the association between hepatitis C virus (HCV) infection and the occurrence of extrahepatic malignancies.
• To compare malignancy rates in HCV-positive patients with those in hepatitis B surface antigen (HBsAg)-positive patients and the general population.

Main Methods:

• Retrospective review of medical records for 103 anti-HCV-positive and 105 HBsAg-positive patients.
• Exclusion of patients diagnosed with malignancy before HCV detection.
• Comparison of observed malignancy rates with data from the Israeli cancer registry.

Main Results:

• Extrahepatic malignancies were diagnosed in 14.6% of anti-HCV-positive patients versus 2.9% of HBsAg-positive patients.
• A significantly higher rate of extrahepatic malignancies was observed in HCV-infected patients aged 55 and older compared to HBsAg-positive patients in the same age group (p < 0.01).
• The overall rate of extrahepatic malignancies in HCV-infected patients was significantly higher than expected in the general population (p < 0.01).

Conclusions:

• A potential association between chronic hepatitis C infection and extrahepatic malignancy may exist.
• Further large-scale prospective studies are necessary to confirm and define this association.
• HCV infection warrants consideration as a risk factor for a broader spectrum of cancers beyond lymphoma.